Pacific Sun Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $540K | Sell |
4,267
-110
| -3% | -$13.9K | 0.28% | 108 |
|
2025
Q1 | $560K | Sell |
4,377
-415
| -9% | -$53.1K | 0.32% | 94 |
|
2024
Q4 | $634K | Sell |
4,792
-355
| -7% | -$46.9K | 0.35% | 89 |
|
2024
Q3 | $749K | Sell |
5,147
-690
| -12% | -$100K | 0.41% | 74 |
|
2024
Q2 | $801K | Sell |
5,837
-460
| -7% | -$63.1K | 0.47% | 63 |
|
2024
Q1 | $864K | Sell |
6,297
-115
| -2% | -$15.8K | 0.5% | 60 |
|
2023
Q4 | $871K | Sell |
6,412
-685
| -10% | -$93.1K | 0.55% | 56 |
|
2023
Q3 | $868K | Sell |
7,097
-750
| -10% | -$91.7K | 0.6% | 51 |
|
2023
Q2 | $1.01M | Buy |
+7,847
| New | +$1.01M | 0.68% | 44 |
|
2022
Q4 | $1.04M | Sell |
7,937
-255
| -3% | -$33.5K | 0.73% | 38 |
|
2022
Q3 | $958K | Sell |
8,192
-345
| -4% | -$40.3K | 0.67% | 44 |
|
2022
Q2 | $1M | Sell |
8,537
-240
| -3% | -$28.2K | 0.66% | 44 |
|
2022
Q1 | $1.14M | Sell |
8,777
-140
| -2% | -$18.2K | 0.63% | 50 |
|
2021
Q4 | $1.36M | Sell |
8,917
-142
| -2% | -$21.7K | 0.73% | 43 |
|
2021
Q3 | $1.47M | Buy |
+9,059
| New | +$1.47M | 0.84% | 37 |
|
2020
Q3 | $1.22M | Buy |
9,029
+725
| +9% | +$98.2K | 1.02% | 28 |
|
2020
Q2 | $1.14M | Sell |
8,304
-285
| -3% | -$39K | 1.02% | 28 |
|
2020
Q1 | $925K | Buy |
8,589
+185
| +2% | +$19.9K | 1.06% | 27 |
|
2019
Q4 | $1.01M | Sell |
8,404
-350
| -4% | -$42.2K | 0.89% | 37 |
|
2019
Q3 | $871K | Sell |
8,754
-175
| -2% | -$17.4K | 0.82% | 47 |
|
2019
Q2 | $974K | Buy |
+8,929
| New | +$974K | 0.93% | 38 |
|
2018
Q2 | $1.09M | Buy |
9,209
+342
| +4% | +$40.5K | 1.12% | 26 |
|
2018
Q1 | $946K | Buy |
+8,867
| New | +$946K | 1.25% | 25 |
|